| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Kardigan Q3 GAAP EPS of -$0.64 beats by $0.43 | 2 | Seeking Alpha | ||
| KARDIGAN Aktie jetzt für 0€ handeln | |||||
| Do | Kardigan, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| Mi | Kardigan, Inc.: Kardigan to Participate in the Jefferies Global Healthcare Conference | 373 | Business Wire | Kardigan, Inc. (Nasdaq: KARD), a precision cardiovascular company, today announced that the Company will participate in a fireside chat at the 2026 Jefferies London Healthcare Conference on Wednesday... ► Artikel lesen | |
| 06.11. | Kardigan completes enrollment in Phase 2b aortic stenosis trial | 2 | Investing.com | ||
| 06.11. | Kardigan, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 04.11. | H.C. Wainwright initiates Kardigan stock coverage with buy rating | 3 | Investing.com | ||
| 21.10. | Baird stuft Kardigan mit "Outperform" ein - Kursziel 43 US-Dollar | 1 | Investing.com Deutsch | ||
| 21.10. | Baird initiates Kardigan stock with Outperform rating, $43 target | 1 | Investing.com | ||
| 16.10. | Kardigan stock initiated at Outperform by William Blair on pipeline | 1 | Investing.com | ||
| 16.10. | Kardigan-Aktie: William Blair nimmt Beobachtung mit "Outperform" auf - Pipeline im Fokus | 1 | Investing.com Deutsch | ||
| 12.10. | UBS startet Coverage für Kardigan mit Kaufempfehlung - Kardiologie-Pipeline als Kurstreiber | 1 | Investing.com Deutsch | ||
| 30.09. | Kardigan, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 09.09. | Kardigan auf Cantor-Konferenz: Plattformansatz für Herzmedikamente | 1 | Investing.com Deutsch | ||
| 17.08. | Citi agrees to acquire Kard Financial for commerce rewards | 3 | The Paypers | ||
| 14.08. | Citi to acquire US rewards tech company Kard Financial | 4 | FinTech Futures | ||
| 14.08. | Citi To Acquire Kard To Supercharge Personalized Rewards And Commerce Media | 3 | pulse2.com | ||
| 14.08. | Citi's U.S. Consumer Cards Business To Buy Kard Financial For Undisclosed Terms | 1.076 | AFX News | WASHINGTON (dpa-AFX) - Banking major Citigroup Inc. (C) announced late Thursday that its U.S. Consumer Cards business has agreed to acquire Kard Financial, a commerce media and rewards platform.... ► Artikel lesen | |
| 13.08. | Citi to acquire commerce rewards platform Kard Financial | 4 | Investing.com | ||
| 13.08. | Citigroup übernimmt Commerce-Prämienplattform Kard Financial | 3 | Investing.com Deutsch | ||
| 11.08. | Kardigan, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| VIATRIS | 18,872 | -0,16 % | Ingram Micro set to join S&P SmallCap 600 following Viatris-Pacira deal | ||
| SYNBIOTIC | 0,101 | -18,39 % | SYNBIOTIC SE: Zuvor aufgezeigte Risiken haben sich materialisiert; Rating und Kursziel under review | SYNBIOTIC hat angekündigt, einen Insolvenzantrag zu stellen, nachdem es dem Unternehmen angesichts anhaltend schwieriger Marktbedingungen nicht gelungen ist, eine ausreichende Finanzierung sicherzustellen.... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,746 | -0,80 % | Organigram Global Inc: Organigram has 180 days to cure Nasdaq non-compliance | ||
| QUANTUM BIOPHARMA | 1,352 | 0,00 % | Quantum BioPharma Non-GAAP EPS of -$0.06 | ||
| NEKTAR THERAPEUTICS | 32,970 | -2,48 % | Nektar Therapeutics verfügt über liquide Mittel von 952,9 Millionen US-Dollar - Finanzierungsreichweite bis Mitte 2028 gesichert | ||
| TONIX PHARMACEUTICALS | 2,716 | -0,37 % | Tonix Q3 2026 slides: TONMYA sales up 37%, shares fall on loss | ||
| ORAMED PHARMACEUTICALS | 3,675 | +8,73 % | ORAMED PHARMACEUTICALS INC. - 10-Q, Quarterly Report | ||
| SELLAS LIFE SCIENCES | 7,180 | +0,28 % | Sellas Life Sciences Group: Regal erreicht die 80. Marke - jetzt wird es ernst | ||
| OPKO HEALTH | 1,530 | 0,00 % | Labcorp To Acquire BioReference Health Assets; OPKO Shares Rise 7.35% | WASHINGTON (dpa-AFX) - Labcorp Holdings Inc. (LH), a provider of innovative and comprehensive laboratory services, on Thursday announced that it had agreed to acquire select assets of BioReference... ► Artikel lesen | |
| JAGUAR HEALTH | 0,405 | 0,00 % | Jaguar Health, Inc.: Jaguar Health to Hold Investor Webcast November 17 Regarding Q3 2026 Financials & Corporate Updates | Company plans to file its Earnings Report on November 16, 2026 on Form 10-Q for the quarter ended September 30, 2026 SAN FRANCISCO, CA / ACCESS Newswire / November 13, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX)... ► Artikel lesen | |
| XORTX THERAPEUTICS | 0,982 | +0,26 % | XORTX Therapeutics Inc. - 6-K, Report of foreign issuer | ||
| OPUS GENETICS | 3,740 | +3,31 % | Citizens reiterates Opus Genetics stock rating on pipeline progress | ||
| SOLIGENIX | 0,321 | 0,00 % | SOLIGENIX, INC.: Soligenix Announces Recent Updates and Third Quarter 2026 Financial Results | PRINCETON, N.J., Nov. 6, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a biopharmaceutical company focused on developing and commercializing products to treat rare... ► Artikel lesen | |
| TALPHERA | 0,770 | 0,00 % | Talphera outlines plan to seek FDA agreement to end NEPHRO enrollment by Dec. 31, 2026, while raising Niyad peak U.S. sales view to over $200M | ||
| SAVARA | 4,376 | +4,07 % | H.C. Wainwright initiates Savara stock coverage with buy rating |